Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 05 May 2009 for UNIGENE LABORATORIES INC.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert F. Hendrickson: trading record in brief
Robert F. Hendrickson discloses dealings in 2 companies, chiefly Cytogen Corp and Unigene Laboratories Inc. In total, 6 filings cover trades dated from 13 June 2007 to 1 May 2009.
On the market, this insider has only ever bought: 1 purchase, €4,684 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants.
The record was last updated on 5 May 2009 with a share grant in Unigene Laboratories Inc. The clock since the last published purchase (17 November 2008) now reads 6,549 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert F. Hendrickson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
10,000 shares0Common StockSEC:0001181431-09-022878:0
10,345 shares@ US$0.58Common StockSEC:0001181431-09-002022:0
10,000 shares@ US$0.59Common StockSEC:0001181431-08-061904:0
Canonical exit: 12 Feb 2009 (T+90)
3,000 sharesCommon StockSEC:0001140361-08-011718:0
10,000 sharesCommon StockSEC:0001140361-08-011718:1
10,000 shares0Common StockSEC:0001140361-07-012412:0
6 of 6 declarations
